RxDoctor Payments Data

Heather Favorito

Rheumatology · Wilmington, NCNPI 1306199674

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,940 of the $8,992 with a category attached, or 77.2%. 28 manufacturers reported payments, led by UCB, Inc. at 24.9% of the total. Reporting peaked in 2019 at $4,818 and has fallen 92.9% since, to $343 in 2025.

$8,992in general payments, 2019–2025

Across 386 payments — averaging $23.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$2K
  • Amgen$2K
  • AbbVie$1K
  • Galderma Laboratories, L.p.$924
  • Pfizer$649
  • Johnson & Johnson$270
  • plus $2K from 22 others

What the payments were for

  • Consulting fees$400%
  • Speaking & faculty fees$2,01222%
  • Food & beverage$6,94077%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,992 in reported general payments places this provider in the 70th percentile of 210 rheumatology providers in North Carolina.

See all rheumatology providers in North Carolina →

Other rheumatology in Wilmington

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →